YOLFTbeta
68

3D Global Biotech Inc.

6808 · TWO · Healthcare / Biotechnology

26.20TWD+0.30 (+1.16%)

Price History

Full chart

Market Stats

Previous Close25.90
Open25.30
Day Range24.90 – 26.45
52-Week Range22.38 – 62.79
Volume78.15K
Market Cap2.62B
P/E (TTM)200.00
Forward P/E0.00
EPS0.17
Dividend Yield0.39%
Beta0.10
50-Day Avg34.38
200-Day Avg36.00

About

3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Keng-Liang Ou
  • Employees43
  • HeadquartersNo.99, Xintai 5th Road, New Taipei City, Taiwan, 221, Taiwan
  • Websitehttps://www.3dglobalbiotech.com.tw

Leadership

  • Mr. Keng-Liang OuChairman & GM
  • Rui Wen HuangDeputy General Manager of Finance Department & Accounting Supervisor
  • Xu An PanChief of R&D

Financials

Income Statement

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue18.18M13.26M11.07M13.64M20.63M265.69M206.74M
Growth (%)--27.05%-16.48%+23.19%+51.24%+1187.68%-22.19%
Cost of Revenue10.25M8.29M9.27M10.93M15.36M91.17M58.33M
Gross Profit7.92M4.97M1.80M2.72M5.27M174.51M148.41M
Gross Margin43.59%37.49%16.28%19.91%25.56%65.68%71.79%
Operating Expense44.23M55.30M64.01M69.00M68.13M85.81M104.19M
Operating Income-36.30M-50.33M-62.21M-66.29M-62.85M88.70M44.22M
Operating Margin-199.73%-379.52%-561.71%-485.87%-304.62%33.39%21.39%
EBITDA-22.42M-24.04M-35.82M-57.02M-35.85M118.02M81.36M
EBITDA Margin-123.34%-181.25%-323.42%-417.91%-173.73%44.42%39.35%
Net Income-36.32M-47.92M-59.70M-67.09M-57.95M91.70M66.53M
Net Income Margin-199.79%-361.35%-539.10%-491.72%-280.87%34.51%32.18%
R&D-35.62M37.60M39.48M38.59M43.27M47.81M
R&D as % of Total Revenue-268.57%339.49%289.36%187.05%16.29%23.13%
Interest Expense49.00K101.00K261.00K255.00K176.00K116.00K1.40M
Interest Expense % of Total Revenue0.27%0.76%2.36%1.87%0.85%0.04%0.68%

Balance Sheet

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets506.18M482.57M424.51M371.26M324.15M1.04B1.09B
Total Liabilities6.38M33.75M34.81M30.66M30.68M132.88M106.12M
Total Equity489.02M448.82M389.71M340.60M293.47M904.69M984.53M
Cash8.71M8.43M20.37M15.53M21.82M56.12M17.45M
Total Debt7.53M20.78M21.31M16.75M10.38M84.76M-
Net Debt-1.19M12.35M935.00K1.22M-11.44M28.64M-

Cash Flow

Currency: TWD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-17.64M-23.23M-35.99M-34.49M-31.61M19.65M110.91M
Investing Cash Flow-120.30M19.77M52.29M18.20M33.58M-494.50M-
Financing Cash Flow126.02M3.17M-4.36M11.45M4.32M509.15M-
Capital Expenditure35.00K30.00K2.88M856.00K778.00K4.91M6.31M
Free Cash Flow-17.67M-23.26M-38.87M-35.34M-32.39M14.74M104.60M
Dividends Paid------41.27M
FCF to OCF100.20%100.13%108.02%102.48%102.46%75.01%94.31%
Dividend Paid to FCF------39.45%

Key Statistics & Ratios

Market Cap2.62B
Enterprise Value2.05B
Trailing P/E200.00
Forward P/E0.00
Price / Sales16.44
Price / Book3.19
EPS0.17
Book Value9.52
Revenue (TTM)159.19M
Gross Profit (TTM)105.86M
EBITDA10.63M
Profit Margin8.92%
Operating Margin-23.92%
Return on Equity1.73%
Return on Assets-0.41%
Shares Outstanding76.98M
Shares Float48.94M
Beta0.10
Dividend Yield0.39%
Dividend Rate0.13
Payout Ratio0.00%

Dividends

20261×
0.13Jul 16, 2026
20251×
0.53Jul 7, 2025